Suppr超能文献

BPIFA1基因在人中耳黏膜中的表达

BPIFA1 Gene Expression in the Human Middle Ear Mucosa.

作者信息

Hadzhiev Yuliyan, Yordanov Stanislav, Popova Diana, Kachakova Darina

机构信息

Department of Ear, Nose and Throat, Tzaritza Ioanna Hospital, Medical University, Sofia, Bulgaria.

Department of Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria.

出版信息

J Int Adv Otol. 2017 Dec;13(3):340-344. doi: 10.5152/iao.2017.4305.

Abstract

OBJECTIVE

The bactericidal/permeability-increasing, fold-containing family member A1 (BPIFA1) gene codes a secretory protein (BPIFA1), which is present in the respiratory tract mucosa, and is part of the innate immune system. This study aimed to prove that BPIFA1 gene expression exists in the human middle ear mucosa.

MATERIALS AND METHODS

In total, 32 patients participated in the study between March 2016 and September 2016. Seventeen patients had chronic otitis media with cholesteatoma (COMC) and 15 had bilateral sensorineural hearing loss (BSHL). The patients with COMC underwent radical mastoidectomy with cholesteatoma removal and those with BSHL underwent cochlear implantation. Part of the processus mastoideus mucosa was examined for BPIFA1 gene expression and the two groups were compared.

RESULTS

For the first time, BPIFA1 gene expression was examined in the mucosa of the human middle ear, and it was verified in 100% (n=32) of the participants. We confirmed that there is a difference in the BPIFA1 expression in 83.33% of the patients with COMC compared to the patients with BSHL but this difference was not statistically significant (p=0.947; probably due to the low number of participants in this group).

CONCLUSION

It is highly likely that the BPIFA1 protein participates in the non-specific immune defense of the middle ear and is relevant to the pathogenesis of the inflammatory diseases of the middle ear.

摘要

目的

杀菌/通透性增加蛋白A1(BPIFA1)基因编码一种分泌蛋白(BPIFA1),该蛋白存在于呼吸道黏膜中,是先天免疫系统的一部分。本研究旨在证实BPIFA1基因表达存在于人类中耳黏膜中。

材料与方法

2016年3月至2016年9月共有32例患者参与本研究。17例患者患有慢性胆脂瘤型中耳炎(COMC),15例患有双侧感音神经性听力损失(BSHL)。COMC患者接受了根治性乳突切除术并切除胆脂瘤,BSHL患者接受了人工耳蜗植入术。对部分乳突黏膜进行BPIFA1基因表达检测并比较两组结果。

结果

首次在人类中耳黏膜中检测到BPIFA1基因表达,所有32例参与者均得到证实。我们确认,83.33%的COMC患者与BSHL患者相比,BPIFA1表达存在差异,但这种差异无统计学意义(p = 0.947;可能是由于该组参与者数量较少)。

结论

BPIFA1蛋白极有可能参与中耳的非特异性免疫防御,并且与中耳炎性疾病的发病机制相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验